Cytiva Cell and Gene Webinars and Podcasts

1. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

   Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.

2. Reducing Timelines And Development Costs Through Scale Up 9/11/2026

   See how an engineering-based approach to bioreactor scale-up delivered comparable cell growth, metabolic profiles, and product performance across cell lines and vessel sizes, helping reduce risks.

3. Scaling AAV Purification: UF/DF Technologies That Deliver 9/11/2026

   Examine a data-driven comparison of hollow-fiber and flat-sheet TFF technologies for AAV manufacturing, covering process performance, scalability, engineering considerations, and cost.

4. How Cell Therapy's Fundamentally Different Model Impacts Patients 9/1/2026

   Examine the evolution of autologous CAR T therapies, their patient-specific manufacturing workflow, key similarities and differences with biologics production, and real-world approaches.

5. Viral Safety Considerations In Process Development 9/1/2026

   Explore how upstream media filtration and downstream anion exchange chromatography can work together to manage viral risk, strengthen AAV process development, and support reliable GMP production.

6. Genomic Medicine At An Inflection Point 9/1/2026

   In vivo therapies and streamlined ex vivo manufacturing are redefining genomic medicine. Understand the tradeoffs, priorities, and technical challenges influencing how future treatments are designed.

7. Automating cell therapy manufacturing without redesigning established workflow 6/24/2026
8. Automating Cell Therapy Manufacturing Without Redesigning Workflows 6/23/2026

   Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

9. Unlocking The Next Wave Of Cancer Vaccines 4/21/2026

   Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.

10. Imagine The Future: An Enhanced Oligonucleotide Synthesis Process 2/9/2026

    Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.